Fig. 3
From: A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
Ex vivo study. Cytotoxicity activity of KIF20A peptide-specific CTL clone against MKN-45 cell lines (open circle) or resting CD8 cells (open square). KIF20A peptide-specific CTL clone exert significantly higher cytotoxicity activity than the resting CD8 T cells. E/T ratio, effector cell (CTL clone or resting CD8)/target cell (tumor cell) ratio. *** p < 0.001, ** p < 0.01, * p < 0.05